Plasma Fibrinogen Levels Are Associated with Epidermal Growth Factor Receptor Gene Mutation in Chinese Patients with Non-Small Cell Lung Cancer

The plasma fibrinogen levels had not only been used as an independent prognostic parameter for the patients with non-small cell lung cancer (NSCLC), but also as a promising biomarker for evaluating the efficacy of chemotherapy. This study aimed to investigate the correlation between the plasma fibrinogen levels and epidermal growth factor receptor (EGFR) gene mutation and clinical-pathological characteristics of Chinese patients with NSCLC.